Judge Blocks Rival Botox Drug In Trade Secrets Trial

By Zach Winnick · March 7, 2012, 9:18 PM EST

A California federal judge on Tuesday barred Merz Pharmaceuticals LLC from selling wrinkle-reducing drug Xeomin, just days before the Botox competitor's nationwide launch, in a bench trial over allegations the company's...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Allergan Inc v. Merz Pharmaceuticals LLC et al

Case Number

Court

California Central

Nature of Suit

Labor: Other

Date Filed

March 18, 2011

Recent Articles By Zach

November 01, 2012
'Price Is Right' Exec Denies Firing Model Over Pregnancy
October 29, 2012
6th Circ. Revives Bankrupt Ex-Worker's Wet Seal Bias Claim
October 25, 2012
Reed Smith Snags Ex-Marcus Employment Pro In Pittsburgh
October 24, 2012
'Price Is Right' Supported Model's Pregnancy, Colleague Says
October 23, 2012
'Price Is Right' Fired Model For Pregnancy, Jury Hears
October 19, 2012
Robert Half's $19M Settlement Of OT Class Action Gets OK
October 18, 2012
LoJack To Pay $8.1M To Settle Calif. Wage Class Claims
October 15, 2012
Prime Healthcare Loses 2nd Bid To Nix Workers' OT Suit
October 11, 2012
Kindred Hospital Workers Push For Class Cert. On OT Claims
October 05, 2012
Calif. Hospital Chain Wins OK On $6M OT Class Deal